BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10419826)

  • 1. Versatile copurification procedure for rapid isolation of homogeneous RAR-RXR heterodimers.
    Iyer J; Bonnier D; Granger F; Iltis C; Andry V; Schultz P; Gronemeyer H
    Protein Expr Purif; 1999 Jul; 16(2):308-14. PubMed ID: 10419826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand- and DNA-induced dissociation of RXR tetramers.
    Chen ZP; Iyer J; Bourguet W; Held P; Mioskowski C; Lebeau L; Noy N; Chambon P; Gronemeyer H
    J Mol Biol; 1998 Jan; 275(1):55-65. PubMed ID: 9451439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAR antagonists diminish the level of DNA binding by the RAR/RXR heterodimer.
    Poujol N; Margeat E; Baud S; Royer CA
    Biochemistry; 2003 May; 42(17):4918-25. PubMed ID: 12718533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties.
    Dong D; Noy N
    Biochemistry; 1998 Jul; 37(30):10691-700. PubMed ID: 9692959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
    Tian K; Norris AW; Lin CL; Li E
    Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently.
    Kersten S; Dawson MI; Lewis BA; Noy N
    Biochemistry; 1996 Mar; 35(12):3816-24. PubMed ID: 8620004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
    Germain P; Iyer J; Zechel C; Gronemeyer H
    Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
    J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of homo- and heterodimerization of retinoid receptors in solution.
    Venepally P; Reddy LG; Sani BP
    Arch Biochem Biophys; 1997 Jul; 343(2):234-42. PubMed ID: 9224735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements.
    Quack M; Carlberg C
    J Mol Biol; 2000 Feb; 296(3):743-56. PubMed ID: 10677278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Millisecond to microsecond time scale dynamics of the retinoid X and retinoic acid receptor DNA-binding domains and dimeric complex formation.
    van Tilborg PJ; Mulder FA; de Backer MM; Nair M; van Heerde EC; Folkers G; van der Saag PT; Karimi-Nejad Y; Boelens R; Kaptein R
    Biochemistry; 1999 Feb; 38(7):1951-6. PubMed ID: 10026278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of RXR-VDR interactions on DR3 DNA.
    Shaffer PL; Gewirth DT
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):215-9. PubMed ID: 15225774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: purification, crystallization, and preliminary X-ray diffraction analysis.
    Bourguet W; Andry V; Iltis C; Klaholz B; Potier N; Van Dorsselaer A; Chambon P; Gronemeyer H; Moras D
    Protein Expr Purif; 2000 Jul; 19(2):284-8. PubMed ID: 10873543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
    Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H
    J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding.
    Figueira AC; Dias SM; Santos MA; Apriletti JW; Baxter JD; Webb P; Neves FA; Simeoni LA; Ribeiro RC; Polikarpov I
    Cell Biochem Biophys; 2006; 44(3):453-62. PubMed ID: 16679533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale expression and purification of the human vitamin D receptor and its ligand-binding domain for structural studies.
    Juntunen K; Rochel N; Moras D; Vihko P
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):297-303. PubMed ID: 10567209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.